Amino acid mapping–guided scaffold selection and hit identification of histidine kinase inhibitors from a virtual library of over 12 million compounds
Abstract Waldiomycin is a natural product originally isolated from actinomycete extracts. It inhibits histidine kinases (HKs), which are essential components of bacterial two-component signal transduction systems, by targeting the conserved H-box region and suppressing autophosphorylation. Here, we identified novel HK inhibitors using amino acid mapping (AAM)-based virtual screening. We compared the AAM descriptor of the naphthoquinone moiety of waldiomycin, which directly interacts with the H-box region, with those of approximately 12 million commercially available compounds and identified 714 candidates with similar descriptor values. From these candidates, we selected 9-hydroxy- 4H -pyrido[1,2- a ]pyrimidin-4-one as a promising and structurally distinct scaffold and synthesized 15 derivatives. The inhibitory activities of these derivatives were evaluated against the HKs WalK, VicK, and EnvZ. Three 4 H -pyrido[1,2- a ]pyrimidin-4-one derivatives ( FF-054 , FF-055 , and FF-060 ) exhibited potent inhibitory activity, with IC 50 values ranging from 4.39 to 259 µM. Notably, the IC 50 values of these compounds increased three- to six-fold against the EnvZ S242A mutant, in which the conserved H-box residue is substituted. Furthermore, nuclear magnetic resonance (NMR) analysis using the EnvZ DHp domain (residues 223–289, encompassing the H-box region) confirmed direct interaction with this domain. Taken together, these results demonstrate that pyrido[1,2- a ]pyrimidin-4-one derivatives FF-054 , FF-055 , and FF-060 are novel HK inhibitors that target the H-box region. This study represents the first successful application of AAM-based screening to identify HK inhibitors targeting this highly conserved region.
Authors
- Shammi Akter (ORCID: https://orcid.org/0009-0008-3283-0005)
- Jun-ichi Haruta
- Akiyoshi Tani (ORCID: https://orcid.org/0000-0001-6578-844X)
- Ryutaro Utsumi
- Masayuki Igarashi (ORCID: https://orcid.org/0000-0002-1562-6685)
- Yoshimasa Ishizaki (ORCID: https://orcid.org/0000-0001-6893-0050)
- Chie Kohayakawa
- Toshihide Okajima (ORCID: https://orcid.org/0000-0003-1733-9580)
- Teruhiko Ishikawa
- Yoko Eguchi (ORCID: https://orcid.org/0000-0003-0506-6554)
- Shino Ohira
- Chigusa Hayashi
- Kyosuke Tsumura
- Kazumasa Sakurai
- Naoki Sawa
- Jiro Nakayama
- Takaomi Katsumoto
- Fumiya Matsumoto
Publication Details
- Journal
- The Journal of Antibiotics
- Published
- 2026-09-30
- DOI
- https://doi.org/10.1038/s41429-026-00953-9
- Primary Topic
- Microbial Natural Products and Biosynthesis
- Type
- article
- Field-Weighted Citation Impact
- 0.00